[Current treatment methods for malaria patients]

Area of Science:

• Tropical medicine
• Pharmacology

Context:

• Malaria remains a significant global health challenge, particularly in tropical regions.
• Drug resistance in Plasmodium falciparum necessitates ongoing evaluation of antimalarial efficacy.
• Understanding treatment options is crucial for effective malaria management.

Purpose:

• To review current antimalarial drugs and their effectiveness.
• To present clinical trial findings for mefloquine, fansidar, fansimeph, and chloroquine.
• To guide individualized drug selection for diverse malaria presentations.

Summary:

• The paper reviews contemporary antimalarial pharmacotherapies.
• Clinical trial results for mefloquine, fansidar, fansimeph, and chloroquine across various malaria forms are provided.
• Treatment decisions must be individualized, considering disease severity, malaria type, and the causative agent's resistance profile.

Impact:

• Informs clinical practice for malaria treatment selection.
• Highlights the importance of considering drug resistance in malaria management.
• Contributes to the evidence base for effective antimalarial drug use in endemic areas.